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Heparin is a polysaccharide-based natural product that is used
clinically as an anticoagulant drug. Heparan sulfate 3-O-sulfotrans-
ferase (3-OST) is an enzyme that transfers a sulfo group to the 3-OH
position of a glucosamine unit. 3-OST is present in multiple iso-
forms, and the polysaccharidesmodifiedby these different isoforms
perform distinct biological functions. 3-OST isoform 1 (3-OST-1) is
the key enzyme for the biosynthesis of anticoagulant heparin. Here,
we report the crystal structure of the ternary complex of 3-OST-1, 3′-
phosphoadenosine 5′-phosphate, and a heptasaccharide substrate.
Comparisons to previously determined structures of 3-OST-3 reveal
unique binding modes used by the different isoforms of 3-OST for
distinguishing the fine structures of saccharide substrates. Our data
demonstrate that the saccharide substrates display distinct confor-
mations when interacting with the different 3-OST isoforms. Site-
directedmutagenesis data suggest that several key amino residues,
including Lys259, Thr256, and Trp283 in 3-OST-3 and Arg268 in 3-
OST-1, play important roles in substrate binding and specificity be-
tween isoforms. These results deepen our understanding of the
biosynthetic mechanism of heparan sulfate and provide structural
information for engineering enzymes for an enhanced biosynthetic
approach to heparin production.
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Heparan sulfate (HS) is a highly sulfated polysaccharide that iscommonly found on the mammalian cell surface and in the
extracellular matrix. HS participates in a wide range of physio-
logical and pathophysiological functions, including embryonic
development, inflammatory responses, blood coagulation, and
assisting viral/bacterial infections (1). HS consists of a disaccha-
ride repeating unit with glucuronic acid (GlcA) or iduronic acid
(IdoA) and glucosamine, each of which is capable of carrying sulfo
groups. The position of the sulfo groups as well as the location of
the IdoA unit dictates the functions of HS (1). The placement of
sulfo groups and IdoA units involves a series of HS biosynthetic
enzymes, including an epimerase and various sulfotransferases.
The heparan sulfate 3-O-sulfotransferases (3-OSTs) are a key sul-
fotransferase family in the HS biosynthetic pathway.
The 3-OSTs transfer a sulfo group to the 3-OH position of an
N-sulfo glucosamine or an N-unsubstituted glucosamine unit to
form 3-O-sulfo glucosamine (GlcNS3S ± 6S or GlcNH23S ± 6S).
The 3-OST family consists of seven different isoforms that enable
introduction of a GlcNS3S unit within distinct carbohydrate
contexts (2). For example, 3-OST-1 sulfates the glucosamine unit
that is flanked by a GlcA unit on its nonreducing side, and 3-OST-
3 sulfates the glucosamine unit that is flanked by an IdoA2S unit
on its nonreducing side (Fig. S1). Consequently, the HS modified
by different 3-OST isoforms displays different affinities to physi-
ological and pathophysiological targets. The HS modified by 3-
OST-1 has high affinity to antithrombin, bestowing this poly-
saccharide with anticoagulant activity, whereas the HS modified
by 3-OST-3 has high affinity to the glycoprotein D of herpes
simplex virus type 1, which serves as an entry receptor for the virus
(3). The distinct roles of 3-O-sulfation in directing HS function
offer a model to understand the regulation of HS biosynthesis,
especially the mechanism used by the isoforms to specifically
recognize the saccharide structures around the modification site.
Understanding the biosynthesis of HS is not only critical for
dissecting its structure–function relationships in vivo, but also plays
a significant role in aiding HS-based drug discovery. Heparin,
a clinically used anticoagulant drug, is a specialized form of HS
that contains a higher sulfation level and ismore densely populated
with IdoA units. Heparin is currently isolated from porcine in-
testine or bovine lung through a poorly regulated supply chain. The
worldwide distribution of contaminated heparin in 2007 raised the
concerns over the safety and reliability of animal-sourced heparins
(4). A cost-effective method for preparing synthetic heparin and
securing the safety of the heparin supply chain is, therefore, highly
desirable. Furthermore, a facile method for preparing heparin
enables engineering of HS/heparin with improved anticoagulant
efficacy and reduced side effects, as well as exploiting heparin or
heparin-like molecules for the development of anticancer and
antiviral drugs (5, 6). Although heparin fragments can be synthe-
sized by a purely chemical method (7), the synthesis is extremely
challenging, especially for products larger than a hexsaccharide. A
new chemoenzymatic approach provides a promising alternative
method to prepare heparin and HS fragments with high efficiency
and purity (8). Improved knowledge of the mechanism of action of
HS biosynthetic enzymes will further enhance the chemoenzymatic
method for preparing therapeutic heparins.
In this article, we report a crystal structure of a ternary complex
of 3-OST-1/3′-phosphoadenosine 5′-phosphate (PAP) with an
acceptor saccharide substrate. Detailed comparison with pre-
viously reported crystal structures of 3-OST-1, 3-OST-3 (9, 10),
and the ternary 3-OST-3/PAP/tetrasaccharide complex, the crys-
tal structure of 3-OST-1/PAP/heptasaccharide reveals different
saccharide binding modes among the 3-OST isoforms (9, 10).
Comparisons to the 3-OST-3/PAP/tetrasaccharide structure sug-
gest that Lys259 in 3-OST-3 plays a key role in binding the 2-O-
sulfo group of IdoA2S on the nonreducing side of the acceptor
site. Despite substrates with the same sequence at the reducing
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end of the substrate, the 3-OSTs bind the substrate in different
orientations. These results suggest that substrate binding by these
enzymes is accomplished through a complex mechanism—not
determined solely by a single saccharide unit, but by an intricate
interplay of substrate sequence and conformation with protein
side chains within the binding cleft.
Results and Discussion
Overall Structure of 3-OST-1/PAP/Heptasaccharide Ternary Complex.
The catalytic domain of 3-OST-1 (Gly48-His311; Fig. 1A) was
cocrystallized with PAP and a synthesized heptasaccharide sub-
strate (Figs. 1B and 2 and Table S1), and crystals of the ternary
complex diffracted at 1.85 Å. This crystal form contained two
molecules per asymmetric unit (rmsd of 0.53 Å over 232 Cα
atoms). The final model contains residues Ser54-His311 in mol-
ecule A, and Thr55-His311 inmolecule B. The PAP—the cofactor
product of sulfo transfer from 3′-phosphoadenosine 5′-phospho-
sulfate (PAPS)—is bound and well-ordered in both molecules.
The protein displays the expected α/βmotif with a phosphosulfate
binding loop interacting with PAP (Fig. 1). The heptasaccharide is
present in the same conformation in both molecules in the
asymmetric unit. The substrate bound in molecule A is very well
defined, but appears to exhibit partial occupancy in molecule B.
Compared with the previously reported 3-OST-1 binary com-
plex (10), the ternary complex revealed no large-scale structural
changes (rmsd of 0.43 Å over 242 Cα atoms) upon acceptor
substrate binding (Fig. S2). The only notable difference between
the binary and ternary complexes is a disordering of the loop
containing residues Asp185–Gly186 in both molecules in the
asymmetric unit in the ternary complex (Fig. 1B). In the binary
complex crystal form, this loop participates in multiple lattice
contacts, likely maintaining its structure. This loop is remotely
located from the substrate binding cleft of 3-OST-1 and would,
therefore, be unlikely to influence binding. The long coil
enclosing the PAP binding site (residues Ala277–Val281) in the
ternary complex is also partially disordered in molecule B;
however, this coil is packed against a neighboring symmetry-re-
lated molecule in molecule A, which helps order this region. The
binding of the heptasaccharide is easily accommodated within
the binding cleft, requiring only slight rearrangements of three
side chains—Arg67, Lys173, and His271.
Interaction Between Heptasaccharide Substrate and 3-OST-1. Of the
two 3-OST-1 molecules in the asymmetric unit, the substrate
binding cleft of molecule A shows significantly clearer density for
the bound substrate than inmolecule B (Fig. 2A). The final refined
model for the substrate in molecule B yields an occupancy of 0.7.
In addition, the substrate bound in molecule A is slightly better
ordered on the reducing end of the sugar, which allows for mod-
eling of the GlcA residue H-6 (Fig. 2A). The electron density for
residue H-6 was not sufficient for modeling in molecule B. Resi-
due H-7, however, is too disordered to model in either molecule.
The heptasaccharide appears to interact in the substrate bind-
ing cleft through a multitude of hydrogen bonding interactions
(Fig. 2B and Fig. S3A). All glucosamine residues in the substrate,
including the nonreducing end terminal sugar (H-1, GlcNAc6S;
Fig. 3A), exhibit a 4C1 chair conformation. The 6-O-sulfate of H-1
interacts only with the backbone amide nitrogen ofHis271, placing
residue H-1 within the “steric gate,” a unique structural motif that
A
B
Fig. 1. Sequence and structure of 3-O-sulfotransferase isoforms. (A) Struc-
ture-based sequence alignment of 3-OST-1 and 3-OST-3. Secondary structural
elements are shown, numbered, and labeled, with α-helices as rectangles
and β-sheets as arrows. Disordered residues Asp185–Gly186 (from molecules
A and B) are shadowed by a cyan box. Residues disordered only in molecule
B are shadowed by an orange box. Catalytic residues are colored in red,
disulfides in yellow, and residues mutated in this study in magenta. (B)
Ribbon diagram of m3-OST-1 with PAP (pink) and bound heptasaccharide
substrate (purple). The substrate bound in molecule A is the most well or-
dered and will therefore be used in all figures. All secondary structural
elements are numbered as in A. Disulfide bond between Cys260 and Cys269
is drawn in yellow. Structural figure was generated using PyMOL (18).
B
A
Fig. 2. Heptasaccharide substrate binding to 3-OST-1. (A) 3-OST-1 second-
ary structural elements shown as a ribbon diagram (green), with the bound
heptasaccharide substrate drawn in stick in purple. Simulated annealing Fo–
Fc omit electron density map (gray) contoured at 2σ. (B) Stereo diagram of
the protein–substrate interactions. The Cα backbone of 3-OST-1 is traced in
tan. Side chains involved in substrate (purple) binding interactions are shown
in green. Putative hydrogen bonding interactions are shown as dashed lines.
PAP is drawn in pink. Stereo diagram was generated using MOLSCRIPT (19).
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reportedly influences the substrate specificity (11). The side chain
of His271 assumes a different rotamer to accommodate the sub-
strate binding within the gate.
H-2, the GlcA residue that confers binding specificity for 3-
OST-1, also adopts the 4C1 chair conformation. There are mul-
tiple putative hydrogen bonding interactions between the car-
boxylate group of GlcA residue H-2 and the positively charged
side chains of Arg72, Lys123, and Lys274 lining the substrate
binding cleft. A possible hydrogen bonding interaction between
the 3-OH of H-2 and Ser273 was also observed.
The acceptor site for sulfation lies in residue H-3, which is
referred to as the acceptor sugar. The 3-OH group of H-3 is
positioned 5.6 Å from the 5′-phosphate of the PAP, suggesting
that the acceptor site would lie within close proximity to the sulfo
donor, allowing transfer of the sulfo group from PAPS to the 3-
OH position. Additionally, the 3-OH is also within hydrogen
bonding distance (2.7 Å) of Glu90, which has been proposed to
act as the general base for an SN2-like in-line displacement re-
action mechanism (12). Binding of the acceptor sugar in this
location is aided by an interaction between the N-sulfo group and
the amide backbone nitrogen of Ala126. Thus, H-3 is held in
a channel between the PAP binding site and a ridge formed by
the loop between β-strand 3 and α-helix 4. The acceptor sugar is
the most ordered unit of the heptasaccharide substrate with an
average B-factor of 28.9 Å2 vs. 38.2 Å2 for the entire ligand.
Away from the acceptor sugar along the oligosaccharide sub-
strate, there is a concomitant increase in thermal motion.
Residue H-4 is a 2-O-sulfo-L-iduronic acid (IdoA2S). Al-
though an IdoA2S can interconvert between the 1C4 chair and
the 2S0 skew-boat conformation (13, 14), the IdoA2S bound to 3-
OST-1 is found in the 1C4 chair conformation. The 2-O-sulfo
group makes a single putative hydrogen bond with Arg197 of 3-
OST-1. The carboxylate group is involved in multiple hydrogen
bonding interactions with Arg67, Asn163, and Asn167. The head
group of Arg67 rotates slightly upon binding of the substrate to
optimize the interaction with H-4.
The penultimate ordered residue on the reducing end of the
substrate is another GlcNS6S (H-5). The 6-O-sulfo group puta-
tively hydrogen bonds with Arg197, whereas the N-sulfo group
binds in a cavity within hydrogen bonding distance of His168,
Lys171, and Lys173 (disordered in the binary complex). In
addition, the 3-OH interacts with the side chain of Asn167.
Residue H-6 makes no hydrogen bonding contacts with the
protein in molecule A, and is correspondingly less ordered than
the rest of the substrate.
Distinct Substrate Conformations for 3-OST-1 and 3-OST-3. Compar-
ison of the structure of the ternary complex of 3-OST-1/PAP/
heptasaccharide with previously reported 3-OST-3/PAP/tetra-
saccharide (structure of the tetrasaccharide shown in Fig. 3B) (9)
reveals different substrate binding modes used by the different
isoforms. The heptasaccharide bound to 3-OST-1 and the tetra-
saccharide bound to 3-OST-3 occupy similar regions of the sub-
strate binding cleft, proximal to the catalytic center (Fig. 4A). The
conformations of the acceptor sugar (residuesH-3 and T-2; Figs. 3
and 4A) are nearly identical, differing only in the torsion of the 6-
O-sulfo group around the C5–C6 bond. In the ternary complexes
of both 3-OST-1 and 3-OST-3, the position of this sulfo group is
likely influenced by an interaction with symmetry-related mole-
cules, consistent with the biochemical evidence that the 6-O-sulfo
group on the acceptor sugar is nonessential for 3-OST-1 or 3-
OST-3 modifications (2). Residues H-2 and T-1, on the non-
reducing side of the acceptor sugar, also adopt nearly identical
conformations, despite being different saccharide entities (GlcA
vs. ΔUA2S, where ΔUA is 4-deoxy-α-L-threo-hex-4-eno-pyr-
anosyluronic acid). The nonreducing saccharide of the tetra-
saccharide substrate carries a ΔUA2S instead of an IdoA2S,
because this tetrasaccharide was isolated from heparin lyase-de-
graded heparin. As a result, the ring conformation of ΔUA2S is
slightly distorted in a 2H1 conformation, flattening one side of the
ring to a planar conformation (Fig. 3B) (9). Based on previous
studies, the 2-O-sulfo group is critical for substrate recognition by
3-OST-3 (3). The key residues in 3-OST-3 responsible for binding
the 2-O-sulfo group are Arg370, Gln255, and Lys259 (Fig. 4B and
Fig. S3B). Of these, the arginine and glutamine are conserved
between 3-OST-1 and 3-OST-3 (Fig. 1A). Lys259 is well conserved
among orthologs of 3-OST-3 (Fig. S4A), but is replaced by the
structurally equivalent Asn167 in 3-OST-1 (Fig. 1A).
Examination of the interactions beyond the acceptor site, to-
ward the reducing end of the substrate, reveals notable differ-
ences. The tetrasaccharide substrate has three reducing-end
saccharide units in common with the heptasaccharide used in the
Fig. 3. Structures of the substrates for 3-O-sulfo-
transferases. (A) The heptasaccharide substrate used
for 3-OST-1 crystallization and mutational analysis. (B)
The tetrasaccharide used for the crystallization of the
ternary complex of 3-OST-3/PAP/tetrasaccharide (9).
(C) The octasaccharide substrate used for analyzing 3-
OST-3 wild-type and mutant proteins described in this
study. The tetrasaccharide and the octasaccharide
were purified from heparin lyase-degraded heparin
(15), whereas the heptasaccharide was enzymatically
synthesized (8). The 3-O-sulfation site in each sub-
strate is indicated by an arrow. The identical tri-
saccharide regions between the heptasaccharide and
tetrasaccharide are depicted in a dashed box. All
substrates are shown with the nonreducing end on
the left and the reducing end on the right.








complex with 3-OST-1 (depicted in a dashed box in Fig. 3 A and
B). Despite this sequence identity, the bound substrates display
surprisingly different conformations. The glycosidic bonds dis-
play significantly distinct angles in this common trisaccharide
domain (Fig. 4C). The tetrasaccharide was found to be “kinked”
around the glycosidic bond between residues T-2 and T-3 (9).
The kink is also observed in the heptasaccharide between resi-
dues H-3 and H-4, but is rotated ∼22.3° with respect to residues
T-2 and T-3 of the tetrasaccharide (via a dihedral defined by C1–
O4–C4–C5; Fig. 4C). An obvious difference between the sub-
strates is found in the conformations of the IdoA2S residues (H-
4 and T-3). In 3-OST-1, this residue adopted the 1C4 chair,
whereas the IdoA2S bound to 3-OST-3 was found in the 2S0
skew-boat conformation (Fig. 4 A and C). Conversion from the
2S0 skew boat to the
1C4 chair conformation moves the 2-O-sulfo
group from the equatorial position to an axial position, which
provides an additional hydrogen bonding interaction with the
Arg197 side chain of 3-OST-1 (Fig. 2B and Fig. S3A). The dif-
ference in the IdoA2S conformations synergistically adds to the
different torsions about the kink, sharply diverting the reducing-
end saccharide units of the two substrates toward different ori-
entations (Fig. 4C). These distinct oligosaccharide conformations
may also play a role in substrate specificity between 3-OST-1 and
3-OST-3. The presence of the 2-O-sulfo group on residue T-1 is
critical for binding to 3-OST-3, whereas this 2-O-sulfo group is
absent on H-2 residue for 3-OST-1. However, if the same residue
was bound to 3-OST-1, in the conformation exhibited in the ter-
nary complex with the heptasaccharide, there would likely be
charge repulsion between the 2-O-sulfo group and the carboxylate
of the IdoA2S on H-4 (Fig. 4B). Altering the reducing side
IdoA2S conformation from 1C4 chair (as in 3-OST-1) to
2S0 skew
boat (as in the 3-OST-3) increases the distance to the carboxylate
group from 2.8 Å (Fig. 4B, pink dashed line) to 3.2 Å (Fig. 4B,
orange dashed line). Thus, the presence of Lys259 in 3-OST-3,
combined with the 2S0 conformation of the T-3 residue, also
alleviates charge repulsion within the substrate.
Another possible contributing factor to the differences in
substrate binding modes between 3-OST-1 and 3-OST-3 may be
found within α-helix 6 (Figs. 1 and 4D). Structural comparison of
the reducing end of the substrate binding clefts of 3-OST-1 and
3-OST-3 shows a notable difference in the length of the α-helix
that forms the top wall of the substrate binding cleft (Figs. 1B
and 4D, red asterisk). This helix consists of residues Pro245–
Lys259 of 3-OST-3 and Pro153–Lys171 of 3-OST-1. The addi-
tional amino acid residues of 3-OST-1 make this helix one entire
helical turn longer than that of 3-OST-3, providing additional
interactions between the protein and the reducing end of the
substrate (Fig. 2B), such as the side chain of His168 of 3-OST-1
that interacts with the N-sulfo group of H-5.
An additional contributing factor to substrate orientation is
the participation of a cation in the binding of enzyme and sub-
strate. A likely sodium ion was observed in the binding cleft of
3-OST-3 (Fig. 4E), which mediates interactions between the
protein and T-4 of the tetrasaccharide (9). This sodium ion is not
present in the structure of the 3-OST-3 apoprotein (PDB ID
code 1T8T), despite having identical sodium concentrations,
suggesting a specific role in substrate binding for 3-OST-3. The
presence of this ion may help orient the T-4 unit of the tetra-
saccharide substrate, increasing its binding affinity.
Mutational Analysis. To explore the possible substrate recognition
mechanisms suggested by crystal studies, we prepared various 3-
OST-1 and 3-OST-3 mutants. Two structurally defined oligosac-
charide substrates were used for the activity and substrate speci-
ficity analysis: the heptasaccharide (3-OST-1 specific) and an
octasaccharide (3-OST-3 specific; Fig. 3 A and C). An octasac-
charide substrate, rather than the tetrasaccharide substrate, was
used for the analysis of 3-OST-3 mutants because the octa-
saccharide substrate exhibited higher binding affinity and suscep-
tibility to 3-OST-3 sulfation. The 3-O-sulfation sites within both
substrates by the respective enzymes are well characterized (8, 15).
The reactivity of the oligosaccharide substrates toward 3-OST-1
and 3-OST-3 modification was measured by the amount of 35S-
labeled products, whereas the substrate selectivity was confirmed
by the product identification using a HPLC method (Table 1 and
SI Materials and Methods). As expected, the susceptibility of the
heptasaccharide to 3-OST-1 modification was 40-fold higher than
modification by 3-OST-3 (Table 1). Conversely, the susceptibility
of the octasaccharide substrate to 3-OST-3 modification was 5.6-
fold higher than modification by 3-OST-1 (Table 1). These results
illustrated basal substrate selectivity by the different 3-OST iso-
forms. We next determined the identities of the 3-O-sulfated oli-
gosaccharide products. Because the oligosaccharide substrates
contain several GlcNS6S units, it is necessary to ensure that only
a single 3-O-sulfo group was introduced onto the acceptor site.We
expected that wild-type 3-OST-1 generates a single 3-O-sulfated
heptasaccharide when it is incubated with its substrate; likewise,
that a single 3-O-sulfated octasaccharide is formed when 3-OST-3
is incubated with the octasaccharide substrate as analyzed by high-




Fig. 4. Comparison of HS binding to 3-OST-1 and 3-OST-3. (A) Comparison
of substrate conformations of the 3-OST-1 bound heptasaccharide (purple)
and the 3-OST-3 bound tetrasaccharide (gray, PDB ID code 1T8U) (9). The
position of the 3-O-sulfation is labeled with a pink asterisk. The surface of 3-
OST-1 is rendered in green. Residues of the heptasaccharide are labeled in
white, as in Fig. 3A. (B) Superposition of 3-OST-1 (green) and 3-OST-3 (gray,
PDB ID code 1T8U) (9) residues involved in binding their respective oligo-
saccharide substrates [heptasaccharide (purple) and tetrasaccharide (light
gray)]. Putative hydrogen bonding interactions between 3-OST-3 and the
tetrasaccharide are shown as dashed lines. The 3-O-sulfation site is labeled
with a pink asterisk. (C) Superposition of the heptasaccharide substrate
(purple) bound to 3-OST-1 with the tetrasaccharide substrate (gray) bound
to 3-OST-3 (PDB ID code 1T8U) (9), highlighting the structural differences
between the reducing ends of the chain. (D) Superposition of 3-OST-1
(green) and 3-OST-3 (gray, PDB ID code 1T8U) (9). PAP from the 3-OST-1
structure is drawn in pink. N and C termini are labeled from each respective
protein. α-helix 6 helix jutting from the top of the substrate binding cleft is
labeled with a red asterisk. (E) Sodium metal ion interactions in the 3-OST-3
substrate binding site. α-helix 6 from 3-OST-3 (9) is shown as a gray ribbon,
and the sodium ion as a purple sphere. Interactions coordinating the sodium
ion are shown as solid black lines. Potential hydrogen bond between Trp283
and the 6-O-sulfo group on residue T-4 is shown as a dashed line.
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Contribution of a sodium ion to substrate specificity. Based on the
crystal structure, Thr256 and Asp252 of 3-OST-3 bind to the
sodium ion (Fig. 4E) (9). Sequence alignments of 3-OST-1 and 3-
OST-3 illustrated that Thr256 is unique to 3-OST-3, and appears
to be evolutionarily well conserved (Fig. S4A). The structurally
homologous residue in 3-OST-1 is a valine (Fig. 1A). To in-
vestigate the role of this residue in substrate binding, Thr256 of
3-OST-3 was replaced with three different residues—alanine,
valine, or glutamate. The 3-OST-3 T256A mutant exhibited re-
activity on the 3-OST-3–specific octasaccharide substrate (Fig.
3C), similar to that of wild-type 3-OST-3, whereas the 3-OST-3
T256V and 3-OST-3 T256E mutants showed increasingly di-
minished reactivity (Table 1). The orthogonal 3-OST-1 V164E
mutant also exhibited severely diminished reactivity on its hep-
tasaccharide substrate (Table 1). Interestingly, product-identity
analysis using DEAE-HPLC revealed that both the 3-OST-1
V164E and the 3-OST-3 T256E mutants generated multiple
sulfation products (Table 1 and Figs. S5 and S6), which would
suggest that glutamate substitution near the reducing end of the
chain may affect substrate binding to 3-OST-3 by prohibiting
interaction via the sodium ion, ultimately increasing the pro-
miscuity of 3-OST-3. It is tempting to speculate that the presence
of the metal ion may help orient the substrate in a catalytically
accessible conformation.
Contribution of reducing-end saccharides to substrate binding and
specificity. Examination of the 3-OST-3 binding pocket sur-
rounding the N-sulfo group of T-4 reveals that one wall is formed
by a tryptophan residue (Trp283). Trp283 is involved in a single
hydrogen bonding interaction with the terminal sugar (Fig. 4E).
This tryptophan is conserved across mammalian orthologs of 3-
OST-3 (Fig. S4A), but not in 3-OST-1 (Fig. 1A and Fig. S4B). In
3-OST-1, this tryptophan is replaced by a tyrosine (Tyr192),
likely resulting in the loss of a hydrogen bond with the reducing
end of the substrate. The 3-OST-3 W283A exhibited greatly di-
minished reactivity (7.6 ± 3.2% compared with wild type; Table
1) and displayed a 41-fold reduction in catalytic efficiency (the
values of kcat/Km; Table S2). It should be noted that the level of
the expression of the 3-OST-3 W283A was severely decreased,
and its behavior suggested concomitantly decreased stability and/
or reduced solubility. Therefore, maintaining the structure of the
sulfate binding pocket near the reducing end of the substrate
binding cleft appears to be crucial for 3-OST-3 structural stability
and reactivity.
Role of α-helix 6 on substrate binding. A series of mutants along
α-helix 6 were prepared. The Lys259 of 3-OST-3 was replaced
with alanine, and the following substitution mutations were cre-
ated in 3-OST-1: N167A, H168A, and K171A. The 3-OST-3
K259A mutant was markedly decreased in reactivity toward the
octasaccharide substrate. The product identity analysis reveals
that 3-OST-3 K259A generated multiple sulfation products (Ta-
ble 1), suggesting that substitution of this lysine residue alters
both reactivity and substrate specificity of the resulting protein.
Because Lys259 interacts with the 2-O-sulfo group that is so
critical for substrate binding by 3-OST-3, this interaction provides
a molecular explanation for substrate specificity at that particular
residue. Lys259 is juxtaposed between the 2-O-sulfo group on T-1,
and the carboxylate group on residue T-3, in an optimal position
to alleviate electrostatic repulsion between them. Unlike the
profound effect by the mutation Lys259 in 3-OST-3, mutations in
α-helix 6 had less of an effect on the enzyme activity and substrate
specificity of 3-OST-1. The individual 3-OST-1 mutants K171A,
N167A, and H168A exhibited only modest decreases in reactivity
toward the heptasaccharide substrate compared with wild type
(Table 1 and Table S2). The 3-OST-1 H168A mutant displayed a
more substantial decrease in reactivity. These mutations in 3-OST-
1 did not appear to affect substrate specificity.
Role of the steric gate in binding to the nonreducing end of the substrate.
It has previously been suggested that the residues interacting
with the nonreducing end of the saccharide substrate could










3-OST-1 WT 100 The anticipated 3-O-sulfated
heptasaccharide was found
18.2 ± 0.9 Multiple products
3-OST-1 V164E 20.3 ± 1.5 Multiple products 2.9 ± 0.9 Not determined
3-OST-1 N167A 40.4 ± 4.2 Similar to wild type 3.9 ± 1.0 Not determined
3-OST-1 H168A 51.1 ± 7.1 Similar to wild type 5.0 ± 3.0 Not determined
3-OST-1 H168E 19.1 ± 1.4 Similar to wild type 2.3 ± 0.9 Not determined
3-OST-1 K171A 83.9 ± 5.0 Similar to wild type 2.2 ± 0.0 Not determined
3-OST-1 R268A 7.2 ± 1.4 Similar to wild type 7.6 ± 2.7 Not determined
3-OST-3 WT 2.5 ± 1.2 Multiple products 100 The anticipated 3-O-sulfated
octasaccharide was found
3-OST-3 T256A 1.1 ± 0.3 Multiple products 101.5 ± 15.3 Similar to wild type
3-OST-3 T256V 2.2 ± 0.3 Multiple products 59.4 ± 10.7 Similar to wild type
3-OST-3 T256E 0.2 ± 0.1 Multiple products 13.1 ± 1.6 Multiple products
3-OST-3 K259A 0.3 ± 0.1 Multiple products 13.1 ± 1.6 Multiple products
3-OST-3 W283A 0.2 ± 0.1 Multiple products 7.6 ± 3.2 Similar to wild type
*Substrate is the 3-OST-1–specific heptasaccharide (Fig. 3A).
†Data presented is the average of three determinations ± SE.
‡Product identities were determined by HPLC analysis using a polyamine-based anion exchange column.
§Substrate is the 3-OST-3–specific octasaccharide (Fig. 3C).
Fig. 5. Long-range nonreducing-end interactions between 3-OST-1 and the
bound heptasaccharide substrate. 3-OST-1 is shown as a surface rendering in
green. The heptasaccharide is drawn in stick in purple. Gate residues His271
and Glu88 are shown in orange. The position of Arg268 is shown in blue.
Residues from the heptasaccharide are labeled in white.








influence substrate specificity via a steric gate motif (11). The
ternary complex of 3-OST-1 with the heptasaccharide substrate
permitted us to view the interaction between the nonreducing-
end saccharide unit and the amino acid residues situated at the
steric gate. Indeed, the saccharide unit on the nonreducing end
of the heptasaccharide (Fig. 5; residue H-1) is positioned directly
between the gate residues His271 and Glu88. Immediately past
the gate, the positively charged side chain of Arg268 may rep-
resent a continuation of the substrate binding cleft (Fig. 5).
Consistent with this conclusion, mutation of Arg268 resulted in
a severe loss of sulfotransferase activity (7.2 ± 1.4% of wild-type
3-OST-1) (Table 1). Decreased sulfotransferase activity corre-
lates well with decreased binding affinity and catalytic efficiency
(Table S2). Because the NH1 atom of Arg268 lies 3.6 Å from the
6-O-sulfo group of residue H-1, there is a favorable electrostatic
interaction and the potential for a long-range hydrogen bonding
interaction, bridged by a water molecule. Also, further extension
of the substrate chain by one residue on the nonreducing end
could place the chain in direct contact with Arg268. The im-
portance of R268A yields insights into the putative behavior of
3-OSTs in the presence of a long HS polysaccharide substrate,
demonstrating that such long-range interactions can affect en-
zyme reactivity distal from the catalytic center. Furthermore, our
results confirm the role of the steric gate to influence substrate
specificity between the 3-OST isoforms (11).
Comparison of Oligosaccharide Conformations When Bound to 3-OST-
1 vs. Antithrombin. It has been demonstrated that 3-O-sulfation of
a pentasaccharide sequence identical to that contained in the 3-
OST-1 substrate (residues H-1 through H-5) used in this study
increases the binding affinity of heparin to antithrombin by 1,000-
fold (16). However, the IdoA2S (H-4) bound to 3-OST-1 is
present in a different conformation. For antithrombin binding,
the equivalent IdoA2S adopts the 2S0 skew-boat conformation,
which is critically important for high-affinity binding to anti-
thrombin (17). When bound to 3-OST-1, however, this IdoA2S
residue in the heptasaccharide—the precursor of the antithrom-
bin-binding pentasaccharide domain—is clearly present in a 1C4
chair conformation. Although the conformation of an IdoA2S
unit is interchangeable between the 1C4 and
2S0 conformations
depending on the protein binding partner (9), a scenario that the
3-O-sulfonation drives the neighboring IdoA2S unit to favor the
2S0 skew-boat conformation is certainly possible.
Conclusions
Unlike that of nucleic acids and proteins, the biosynthesis of HS
polysaccharide is not a template-driven process. HS sulfotrans-
ferases, including 3-OSTs, are primarily responsible for controlling
the sulfation patterns in HS, which consequently determine the
function of HS polysaccharides. The unique functions of 3-O-sul-
fated HS underscore the importance of investigating the mecha-
nism for the control of HS biosynthesis. Although we have solved
the ternary complex structure of 3-OST-3/PAP/tetrasaccharide (9),
the substrate recognition mechanism remained unclear due to the
lack of the ternary structure of other 3-OST isoforms, especially
3-OST-1. Despite that the binary structure of 3-OST-1/PAP was
initially solved in 2003, our recent success in synthesizing structur-
ally homogeneous HS oligosaccharides provides a vital reagent for
completing this study (8). The substrate is synthesized to a length
sufficient for displaying the interactions between the saccharides
with the key amino acid residues of 3-OST-1. Our findings dem-
onstrate that each 3-OST isoform provides a unique perspective on
modes of substrate binding and transforms the polysaccharides with
distinct sulfation patterns. The structural information lays a foun-
dation for targeted protein engineering toward the development
of an enzyme-based approach to synthesize heparin and HS. These
efforts will enhance the ability of enzyme-based synthetic methods,
leading to specifically tailored heparin with anticoagulation, anti-
cancer, and other potentially therapeutic uses.
Materials and Methods
Crystals of the 3-OST-1/PAP/heptasaccharide complex were obtained using a
microbatch technique, by mixing 1.5 μL of the complex [12.9 mg/mL 3-OST-1, 5
mMheptasaccharide, 4 mM PAP, 23.6 mM Tris (pH 7.5), 142mMNaCl] with 2.5
μL of 0.1 M sodium citrate (pH 5.5) and 20% (wt/vol) PEG 3000. The hepta-
saccharidewas synthesized through a chemoenzymatic approach as previously
described (8), and the structure was confirmed by ESI-MS analysis (Fig. S7).
Crystals grew to a usable size after 10-d incubation at room temperature. The
crystals were transferred in two steps to a cryoprotectant solution containing
0.1 M sodium citrate (pH 5.5), 0.1 M NaCl, 4 mM PAP, 20 mM heptasaccharide,
30% (wt/vol) PEG3000, and 7.6% (vol/vol) ethylene glycol. Following cry-
oprotection, the crystals were flash frozen in liquid nitrogen and placed into
a stream of liquid nitrogen gas cooled to −180 °C for data collection. The data
were collected at 1.85 Å on the Southeast Regional Collaborative Access Team
22-IDbeamline at theAdvanced Proton Source, ArgonneNational Laboratory.
Additional experimental procedures are presented in SI Materials
and Methods.
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